BioCentury
ARTICLE | Clinical News

BPX-101: Interim Phase I/II data

April 26, 2010 7:00 AM UTC

Interim data from a Phase I/II trial in 6 evaluable patients showed that low- and mid-doses of intradermal BPX-101 given every other week in combination with AP1903 for 6 doses produced 4 cases of sta...